Reduced MEK Inhibition Preserves Genomic Stability in Naive Human Embryonic Stem Cells
Overview
Pathology
Authors
Affiliations
Human embryonic stem cells (hESCs) can be captured in a primed state in which they resemble the postimplantation epiblast, or in a naive state where they resemble the preimplantation epiblast. Naive-cell-specific culture conditions allow the study of preimplantation development ex vivo but reportedly lead to chromosomal abnormalities, which compromises their utility in research and potential therapeutic applications. Although MEK inhibition is essential for the naive state, here we show that reduced MEK inhibition facilitated the establishment and maintenance of naive hESCs that retained naive-cell-specific features, including global DNA hypomethylation, HERVK expression, and two active X chromosomes. We further show that hESCs cultured under these modified conditions proliferated more rapidly; accrued fewer chromosomal abnormalities; and displayed changes in the phosphorylation levels of MAPK components, regulators of DNA damage/repair, and cell cycle. We thus provide a simple modification to current methods that can enable robust growth and reduced genomic instability in naive hESCs.
Transposable element activity captures human pluripotent cell states.
Levin-Ferreyra F, Kodali S, Cui Y, Pashos A, Pessina P, Brumbaugh J EMBO Rep. 2024; 26(2):329-352.
PMID: 39668246 PMC: 11772670. DOI: 10.1038/s44319-024-00343-y.
Halter K, Chen J, Priklopil T, Monfort A, Wutz A Chromosome Res. 2024; 32(4):12.
PMID: 39390295 PMC: 11467062. DOI: 10.1007/s10577-024-09756-w.
Early human development and stem cell-based human embryo models.
Shahbazi M, Pasque V Cell Stem Cell. 2024; 31(10):1398-1418.
PMID: 39366361 PMC: 7617107. DOI: 10.1016/j.stem.2024.09.002.
Manipulating cell fate through reprogramming: approaches and applications.
Yagi M, Horng J, Hochedlinger K Development. 2024; 151(19).
PMID: 39348466 PMC: 11463964. DOI: 10.1242/dev.203090.
Current genetic models for studying congenital heart diseases: Advantages and disadvantages.
Shorbaji A, Pushparaj P, Bakhashab S, Al-Ghafari A, Al-Rasheed R, Mira L Bioinformation. 2024; 20(5):415-429.
PMID: 39132229 PMC: 11309114. DOI: 10.6026/973206300200415.